Kazutaka Nanba1,2, William E Rainey2,3. 1. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. 2. Department of Molecular and Integrative Physiology. 3. Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA.
Abstract
PURPOSE OF REVIEW: Renin-independent aldosterone production from one or both affected adrenal(s), a condition known as primary aldosteronism (PA), is a common cause of secondary hypertension. In this review, we aimed to summarize recent findings regarding pathophysiology of bilateral forms of PA, including sporadic bilateral hyperaldosteronism (BHA) and rare familial hyperaldosteronism. RECENT FINDINGS: The presence of subcapsular aldosterone synthase (CYP11B2)-expressing aldosterone-producing micronodules, also called aldosterone-producing cell clusters, appears to be a common histologic feature of adrenals with sporadic BHA. Aldosterone-producing micronodules frequently harbor aldosterone-driver somatic mutations. Other potential factors leading to sporadic BHA include rare disease-predisposing germline variants, circulating angiotensin II type 1 receptor autoantibodies, and paracrine activation of aldosterone production by adrenal mast cells. The application of whole exome sequencing has also identified new genes that cause inherited familial forms of PA. SUMMARY: Research over the past 10 years has significantly improved our understanding of the molecular pathogenesis of bilateral PA. Based on the improved understanding of BHA, future studies should have the ability to develop more personalized treatment options and advanced diagnostic tools for patients with PA.
PURPOSE OF REVIEW: Renin-independent aldosterone production from one or both affected adrenal(s), a condition known as primary aldosteronism (PA), is a common cause of secondary hypertension. In this review, we aimed to summarize recent findings regarding pathophysiology of bilateral forms of PA, including sporadic bilateral hyperaldosteronism (BHA) and rare familial hyperaldosteronism. RECENT FINDINGS: The presence of subcapsular aldosterone synthase (CYP11B2)-expressing aldosterone-producing micronodules, also called aldosterone-producing cell clusters, appears to be a common histologic feature of adrenals with sporadic BHA. Aldosterone-producing micronodules frequently harbor aldosterone-driver somatic mutations. Other potential factors leading to sporadic BHA include rare disease-predisposing germline variants, circulating angiotensin II type 1 receptor autoantibodies, and paracrine activation of aldosterone production by adrenal mast cells. The application of whole exome sequencing has also identified new genes that cause inherited familial forms of PA. SUMMARY: Research over the past 10 years has significantly improved our understanding of the molecular pathogenesis of bilateral PA. Based on the improved understanding of BHA, future studies should have the ability to develop more personalized treatment options and advanced diagnostic tools for patients with PA.
Authors: Geok Chin Tan; Giulia Negro; Alexandra Pinggera; Nur Maya Sabrina Tizen Laim; Isa Mohamed Rose; Jiri Ceral; Ales Ryska; Long Kha Chin; Nor Azmi Kamaruddin; Norfilza Mohd Mokhtar; A Rahman A Jamal; Norlela Sukor; Miroslav Solar; Joerg Striessnig; Morris Jonathan Brown; Elena Aisha Azizan Journal: Hypertension Date: 2017-06-05 Impact factor: 10.190
Authors: Koshiro Nishimoto; Scott A Tomlins; Rork Kuick; Andi K Cani; Thomas J Giordano; Daniel H Hovelson; Chia-Jen Liu; Aalok R Sanjanwala; Michael A Edwards; Celso E Gomez-Sanchez; Kazutaka Nanba; William E Rainey Journal: Proc Natl Acad Sci U S A Date: 2015-08-03 Impact factor: 11.205
Authors: Na Sun; Lucie S Meyer; Annette Feuchtinger; Thomas Kunzke; Thomas Knösel; Martin Reincke; Axel Walch; Tracy Ann Williams Journal: Hypertension Date: 2020-01-20 Impact factor: 10.190
Authors: Andrea G Maria; Mari Suzuki; Annabel Berthon; Crystal Kamilaris; Andrew Demidowich; Justin Lack; Mihail Zilbermint; Fady Hannah-Shmouni; Fabio R Faucz; Constantine A Stratakis Journal: Am J Hypertens Date: 2020-02-22 Impact factor: 3.080
Authors: Georgios Daniil; Fabio L Fernandes-Rosa; Jean Chemin; Iulia Blesneac; Jacques Beltrand; Michel Polak; Xavier Jeunemaitre; Sheerazed Boulkroun; Laurence Amar; Tim M Strom; Philippe Lory; Maria-Christina Zennaro Journal: EBioMedicine Date: 2016-10-04 Impact factor: 8.143